Metrics are central to efforts to rein in clinical trials that are either poorly initiated or have incurred unforeseen events, which place the original timelines and/or budgets at risk of overages. They also drive competitive performance among those organizations performing trials.
Business Intelligence (BI) has become an increasingly popular topic in clinical trials as clinical project managers are expected to make smarter decisions on intelligence derived from clinical trial data. In addition, sponsors/CROs are looking for ways to incorporate BI into the eClinical systems they are using to empower oversight – turning raw clinical trial data into actionable information.
Having technology which can automate or assist in the timely monitoring of clinical trials is a huge improvement over the current ‘status quo’ of manual methods such as spreadsheets. These manual methods are cumbersome and erroneous, not to mention they only provide a dated snapshot of clinical trial performance. But how do metrics drive performance competitiveness?
In this webinar we will explore:
- Business Intelligence: The need to make smarter decisions on intelligences derived from clinical trial data
- Industry trends on data mining and analytics
- The need for industry benchmarking across clinical trials and its inherent challenges
- Moving beyond benchmarking to gamification, efficient resource allocation, and predictive analytics or forecasting
This webinar is applicable to:
- Sponsor and CRO roles responsible for site selection and activation
- Sponsor and CRO roles responsible for collecting and evaluating clinical trial metrics
Barry Milton, Head of Business Operations, Novartis
Barry is a clinical trial and operations management expert. His experiences as an Oncology nurse, clinical trial coordinator and his senior management roles at Novartis, Roche, Merck, and AstraZeneca provides him with a well-rounded set of skills and experiences in the clinical trial space.Message Presenter
Jeffrey Kasher, President, Patients Can't Wait
Jeff Kasher is a known pharmaceutical development change expert with 28 years of experience at Eli Lilly. He is passionate for improving outcomes, bringing patients and research sites into the development process, and dramatically decreasing time to market. His expertise includes novel product development from bench through market launch, research and clinical trial leadership, innovation center start up as well as new industry paradigm creation.
Jeff is President of Patients Can’t Wait, Chairman of Advisory Board for DrugDev as well as member of Advisory Board of TrialReach, Cytolon, and goBalto. He sits on the DPharm steering committee and faculty, and is a member of Linking Leaders. In 2013 CenterWatch Jeff was named one of the “20 Innovators Changing the Face of the Clinical Trials Industry.” He received a B.S. in Chemistry from Franklin & Marshall College, a Ph.D. in Pharmacology from the State University of New York, and a Post-Doctoral Fellowship in Physiology at Yale University School of Medicine.
Rob Wynden, VP Technology & Engineering, goBalto
Rob has been a computer scientist and programmer for over 30 years in the scientific programming, e-commerce, biotech, and health care industries. He implemented study startup and CTMS functionality at 9 bay are biotech companies, and invented a method that allows medical and biotech organizations to use cloud-based analytics to monitor patient data. He holds a BS in Computer Engineering from Sacramento State University and a PhD in Biological and Biomedical Clinical Informatics from UCSF.Message Presenter
Who Should Attend?
Senior level professionals involved in:
- Clinical Operations
- Regulatory Compliance
- Project Management
- Regulatory Affairs
- Operational Oversight
- Clinical Reporting
goBalto is the industry leader in cloud-based study startup software for the global life sciences industry, offering the only complete end-to-end platform for starting clinical trials, from site identification, feasibility assessment and selection through to activation, with comprehensive metrics to track adherence to timelines and budget. Committed to accelerating clinical trials through innovation, product excellence, and customer success, goBalto works with over half of top 20 Pharma and top 10 CROs. Our customers include: Covance, CMIC HOLDINGS, Genentech Roche, ICON, INC Research, Novartis and PSI CRO. goBalto is headquartered in San Francisco, with offices in Pennsylvania and Singapore. For more information, visit www.gobalto.com